Breaking News
Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
30.70 -0.10    -0.32%
22/09 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US7170811035 
S/N:  852009
  • Volume: 4,538
  • Bid/Ask: 30.65 / 30.70
  • Day's Range: 30.50 - 31.25
Pfizer 30.70 -0.10 -0.32%

PFE Income Statement

 
Featured here, the Income Statement (earnings report) for Pfizer Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
02/07
2023
02/04
2022
31/12
2022
02/10
Total Revenue 12734 18282 24290 22638
Revenue 12734 18282 24290 22638
Other Revenue, Total - - - -
Cost of Revenue, Total 2932 4747 9991 6037
Gross Profit 9802 13535 14299 16601
Total Operating Expenses 10077 11620 18591 12489
Selling/General/Admin. Expenses, Total 3332 3276 3854 2934
Research & Development 2629 2494 3615 2696
Depreciation / Amortization 384 366 374 355
Interest Expense (Income) - Net Operating -508 -318 -313 -311
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 1308 1055 1070 778
Operating Income 2657 6662 5699 10149
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 130 -444 86 -119
Other, Net 258 836 383 1268
Net Income Before Taxes 2269 6270 5230 9000
Provision for Income Taxes -71 715 230 356
Net Income After Taxes 2340 5555 5000 8644
Minority Interest 274 266 256 259
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 2329 5542 4992 8629
Total Extraordinary Items -2 1 2 -21
Net Income 2327 5543 4994 8608
Total Adjustments to Net Income 2 -1 -2 21
Income Available to Common Excluding Extraordinary Items 2329 5542 4992 8629
Dilution Adjustment -15.33 -12.19 -12.11 -26.18
Diluted Net Income 2342.33 5555.19 5006.11 8634.18
Diluted Weighted Average Shares 5713 5727 5743 5718
Diluted EPS Excluding Extraordinary Items 0.41 0.97 0.872 1.51
DPS - Common Stock Primary Issue 0.41 0.41 0.4 0.4
Diluted Normalized EPS 0.336 0.788 0.668 1.15
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
George Galloway
George Galloway Sep 22, 2023 1:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sad company with zero leadership and zero vision.
damian del
mudlog79 Sep 22, 2023 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dump this trash
Hisham Chehab
Hisham Chehab Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can anyone provide a good vision for this stock plz.
Thị Mỹ Thuận Trần
Thị Mỹ Thuận Trần Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30 $ soon
Crim Jamer
Crim Jamer Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just believe what you see. I bought calls on last friday, they are almost total loss now.
Jay Clerk
Jay Clerk Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If you get your bews from the mainstream then your bound to ve a victim , you just wont get it . Been shorting since 52$ havent let up once its going to 20s! This company is run by satan!
Jay Clerk
Jay Clerk Sep 18, 2023 6:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Poopiest stock that ever circled the toilet
George Galloway
George Galloway Sep 13, 2023 1:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
change at CEO is very much needed
liebe dich ich
liebe dich ich Sep 13, 2023 6:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wtf Pfizer stock? CEO should retire and get down his salary!
Jay Clerk
Jay Clerk Sep 12, 2023 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nobody with common sense will be getting another death jabbed. You have to be crazy to put that poisen in your viens
aux fipe
aux fipe Sep 12, 2023 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hooked on Phonics is a great tool.
Anand Guru
Anand Guru Sep 11, 2023 10:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Read as FDA approval
Anand Guru
Anand Guru Sep 11, 2023 10:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer gets approval from NDA For 2023 -2024
Vlas Dacian
Vlas Dacian Sep 11, 2023 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30-31$ buy area
Jay Clerk
Jay Clerk Sep 11, 2023 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Im thinking more like17$
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email